CEP72 Activators
Phosphatidylinositol 3,4,5-trisphosphate (PIP3), N6-(4-Hydroxybenzyl)adenosine, and 8-CPT-cAMP are signaling molecules that have a potential to enhance CEP72 function indirectly by activating specific pathways that are part of cell cycle progression and centrosome duplication. For instance, PIP3 activates the AKT/mTOR pathway which is known to regulate these processes. Olomoucine is a CDK1 inhibitor that causes cell cycle arrest, potentially increasing the necessity for the function of CEP72 in centrosome duplication. Similarly, VX-680 is an Aurora A kinase inhibitor that, by disrupting normal centrosome maturation and separation, could potentially enhance the function of CEP72.
On the other hand, compounds like Olomoucine, VX-680 (Tozasertib), BI 2536, LY294002, U0126, Rapamycin, Nutlin-3, and PD0332991 (Palbociclib) are inhibitors of various proteins that play key roles in cell cycle progression and centrosome duplication. By inhibiting these proteins, these compounds could potentially disrupt normal cell cycle progression or centrosome maturation and separation, potentially enhancing the function of CEP72.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Olomoucine is a CDK1 inhibitor. By inhibiting CDK1, it causes cell cycle arrest, which may increase the necessity for the function of CEP72 in centrosome duplication. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
Tozasertib is an Aurora A kinase inhibitor. Inhibiting Aurora A kinase disrupts normal centrosome maturation and separation, processes which could potentially enhance the function of CEP72. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
BI 2536 is a PLK1 inhibitor. By inhibiting PLK1, it disrupts centrosome maturation and separation, potentially enhancing the function of CEP72. | ||||||
8-CPT-cAMP | 93882-12-3 | sc-201569 sc-201569A | 20 mg 100 mg | $87.00 $316.00 | 19 | |
This cAMP analogue activates the PKA pathway. PKA signaling could potentially enhance the function of CEP72 in centrosome duplication. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. Inhibiting PI3K could potentially disrupt normal cell cycle progression, enhancing the function of CEP72 in centrosome duplication. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. Inhibition of mTOR disrupts normal cell cycle progression, potentially enhancing the function of CEP72 in centrosome duplication. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 activates p53, a key regulator of the cell cycle. Activation of p53 could potentially enhance the function of CEP72 in centrosome duplication. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a CDK4/6 inhibitor. Inhibiting CDK4/6 could potentially disrupt normal cell cycle progression, enhancing the function of CEP72 in centrosome duplication. | ||||||